Kuros Biosciences AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	146.06	85.16	39.86	19.45	15.15
Revenue Growth (YoY)	71.51%	113.65%	104.92%	28.35%	231.96%
Cost of Revenue	18.61	9.49	6.05	3.91	4.11
Gross Profit	127.45	75.67	33.81	15.54	11.04
Selling, General & Admin	107.95	67.81	37.73	20.96	15.41
Research & Development	10.67	7.87	2.41	5.62	5.47
Other Operating Expenses	-0.13	-0.13	-0.29	-0.39	-0.23
Operating Expenses	118.5	75.55	39.85	26.19	20.66
Operating Income	8.95	0.12	-6.04	-10.65	-9.62
Interest Expense	-0.37	-0.17	-0.22	-	-1.52
Interest & Investment Income	0.1	0.18	-	-	0.65
Currency Exchange Gain (Loss)	-3.56	1.32	-2.73	-0.86	-
Other Non Operating Income (Expenses)	-0.11	0.52	2.77	-1.89	-
EBT Excluding Unusual Items	5.02	1.98	-6.22	-13.4	-10.48
Impairment of Goodwill	-	-5.75	-5.19	-3.89	-
Asset Writedown	-	-	-0.2	-	-
Pretax Income	5.02	-3.77	-11.61	-17.29	-10.48
Income Tax Expense	2.55	0.42	0.45	-1.51	-2.21
Earnings From Continuing Operations	2.46	-4.19	-12.06	-15.78	-8.27
Earnings From Discontinued Operations	0.09	-0.65	-4.24	-	-
Net Income	2.55	-4.84	-16.3	-15.78	-8.27
Net Income to Common	2.55	-4.84	-16.3	-15.78	-8.27
Shares Outstanding (Basic)	38	37	37	34	33
Shares Outstanding (Diluted)	41	37	37	34	33
Shares Change (YoY)	11.26%	1.69%	7.91%	3.37%	34.86%
EPS (Basic)	0.07	-0.13	-0.45	-0.47	-0.25
EPS (Diluted)	0.06	-0.13	-0.45	-0.47	-0.25
Free Cash Flow	-2.89	2.31	-10.88	-8.37	-6.32
Free Cash Flow Per Share	-0.07	0.06	-0.30	-0.25	-0.19
Gross Margin	87.26%	88.85%	84.83%	79.89%	72.86%
Operating Margin	6.13%	0.14%	-15.15%	-54.74%	-63.46%
Profit Margin	1.75%	-5.68%	-40.90%	-81.15%	-54.59%
Free Cash Flow Margin	-1.98%	2.71%	-27.29%	-43.05%	-41.72%
EBITDA	11.52	2.32	-3.55	-8.11	-6.96
EBITDA Margin	7.89%	2.72%	-8.91%	-41.70%	-45.90%
D&A For EBITDA	2.57	2.2	2.49	2.54	2.66
EBIT	8.95	0.12	-6.04	-10.65	-9.62
EBIT Margin	6.13%	0.14%	-15.15%	-54.74%	-63.46%
Effective Tax Rate	50.91%	-	-	-	-
Revenue as Reported	146.06	85.16	39.86	19.45	15.15

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.